Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent liti...
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
© Norton Rose Fulbright LLP 2026